nalidixic acid and amphotericin b

nalidixic acid has been researched along with amphotericin b in 25 studies

Research

Studies (25)

Timeframe	Studies, this research(%)	All Research%
pre-1990	10 (40.00)	18.7374
1990's	3 (12.00)	18.2507
2000's	3 (12.00)	29.6817
2010's	8 (32.00)	24.3611
2020's	1 (4.00)	2.80

Authors

Authors	Studies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Davies, J; Schindler, D	1
Fowst, G; Nessi, R	1
Buckingham, JM; Freeburg, PW	1
Dougherty, PF; Matthews, TR; Yotter, DW	1
Guiot, HF; Tordoir-van der Bent, EF	1
Petrou, MA; Rogers, TR	1
Plempel, M	1
Aber, VR; Allen, BW; Carrol, L; Dickinson, JM; Mitchison, DA	1
Crowder, JG; Gilkey, GH; White, AC	1
Andrews, JW; Conville, PS; Witebsky, FG	1
English, L; Keane, CT; O'Morain, CA; Xia, HX	1
Palomino, JC; Portaels, F	1
Chang, CL; Kim, CM; Kim, HH; Lee, EY; Oh, SH; Park, TS; Son, HC	1
SENECA, H	1
Ghanotakis, DF; Trikeriotis, M	1
Dietze, R; Johnson, JL; Loureiro, RB; Maciel, EL; Palaci, M; Peres, RL	1
Babak, V; Kralik, P; Kubickova, L; Pavlik, I; Pribylova, R	1
Bullman, S; Corcoran, D; De Barra, L; Koziel, M; Lucey, B; O'Doherty, A; Sleator, RD	1
Joseph, A; Muzanyi, G; Nassali, J; Peace, A; Wamuntu, B	1

Reviews

3 review(s) available for nalidixic acid and amphotericin b

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Inhibitors of macromolecular synthesis in yeast. Methods in cell biology, 1975, Volume: 12 Topics: Acriflavine; Amphotericin B; Anisomycin; Anti-Bacterial Agents; Antineoplastic Agents; Cycloheximide; Dactinomycin; Daunorubicin; Deoxyadenosines; Depression, Chemical; DNA; Ethidium; Fluorouracil; Fungal Proteins; Hydroxyurea; Mitomycins; Nalidixic Acid; Phenazines; Phenylethyl Alcohol; Porfiromycin; Puromycin; RNA; Saccharomyces cerevisiae; Streptonigrin; Sulfanilamides; Triaziquone; Trichothecenes; Uracil	1975
Clinical use of rifampicin in combination for non-mycobacterial infections: a survey of published evidence. The Journal of international medical research, 1979, Volume: 7, Issue:3 Topics: Amphotericin B; Cephalosporins; Chloramphenicol; Colistin; Drug Therapy, Combination; Endocarditis, Bacterial; Erythromycin; Gentamicins; Humans; Kanamycin; Lincomycin; Mycoses; Nalidixic Acid; Penicillins; Pseudomonas Infections; Respiratory Tract Infections; Rifampin; Staphylococcal Infections; Sulfamethoxazole; Tetracyclines; Trimethoprim; Urinary Tract Infections; Vancomycin	1979

Other Studies

22 other study(ies) available for nalidixic acid and amphotericin b

Article	Year
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22 Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship	2012
Evaluation of the Bacti-Lab streptococci culture systems for selective recovery and identification of group A streptococci. Journal of clinical microbiology, 1976, Volume: 3, Issue:4 Topics: Agar; Amphotericin B; Animals; Bacitracin; Bacteriological Techniques; Blood; Evaluation Studies as Topic; False Positive Reactions; Humans; Nalidixic Acid; Neomycin; Pharynx; Pseudomonas aeruginosa; Sheep; Staphylococcus aureus; Streptococcus	1976
Microdilution transfer plate technique for determining in vitro synergy of antimicrobial agents. Antimicrobial agents and chemotherapy, 1977, Volume: 11, Issue:2 Topics: Amphotericin B; Anti-Infective Agents; Culture Media; Drug Synergism; Gentamicins; Methods; Microbial Sensitivity Tests; Nalidixic Acid; Rifampin	1977
Prolonged granulocytopenia due to selective antimicrobial modulation of the intestinal flora: bias or biology? Progress in clinical and biological research, 1985, Volume: 181 Topics: Agranulocytosis; Amphotericin B; Animals; Granulocytes; Humans; Mice; Mice, Inbred Strains; Nalidixic Acid; Nystatin; Polymyxin B; Polymyxins	1985
In-vitro activity of antifungal agents in combination with four quinolones. Drugs under experimental and clinical research, 1988, Volume: 14, Issue:1 Topics: 4-Quinolones; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Candida; Candida albicans; Ciprofloxacin; Drug Combinations; Enoxacin; Flucytosine; Mepartricin; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolines; Saccharomyces cerevisiae	1988
[Action mechanism of antibacterial and antifungal drugs]. Der Internist, 1967, Volume: 8, Issue:6 Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bacitracin; Bacteria; Cephalosporins; Chloramphenicol; Cycloserine; Daunorubicin; Fungi; Isoniazid; Mitomycins; Nalidixic Acid; Nystatin; Penicillins; Polymyxins; Puromycin; Sulfonamides	1967
A selective oleic acid albumin agar medium for tubercle bacilli. Journal of medical microbiology, 1972, Volume: 5, Issue:2 Topics: Agar; Albumins; Amphotericin B; Bacitracin; Carbenicillin; Cell Survival; Centrifugation; Cloxacillin; Culture Media; Dithiothreitol; Humans; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium bovis; Mycobacterium tuberculosis; Nalidixic Acid; Nystatin; Oleic Acids; Penicillin Resistance; Polymyxins; Sputum; Trimethoprim	1972
Serratia marcescens bacteremia. Clinical observations and studies of precipitin reactions. Archives of internal medicine, 1971, Volume: 128, Issue:2 Topics: Adult; Aged; Amphotericin B; Ampicillin; Antibodies; Bacteriuria; Cephalothin; Chloramphenicol; Female; Gentamicins; Humans; Immunodiffusion; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Penicillins; Precipitin Tests; Sepsis; Serratia marcescens; Sputum; Streptomycin; Tetracycline	1971
Effect of PANTA on growth of Mycobacterium kansasii in BACTEC 12B medium. Journal of clinical microbiology, 1995, Volume: 33, Issue:8 Topics: Amphotericin B; Azlocillin; Bacteriological Techniques; Culture Media; Drug Resistance, Microbial; Drug Therapy, Combination; Evaluation Studies as Topic; Humans; Mycobacterium Infections, Nontuberculous; Nalidixic Acid; Nontuberculous Mycobacteria; Polymyxin B; Trimethoprim	1995
Enhanced cultivation of Helicobacter pylori in liquid media. Journal of clinical pathology, 1993, Volume: 46, Issue:8 Topics: Amphotericin B; Bacteriological Techniques; Colony Count, Microbial; Culture Media; Helicobacter pylori; Humans; Nalidixic Acid; Time Factors; Vancomycin	1993
Effects of decontamination methods and culture conditions on viability of Mycobacterium ulcerans in the BACTEC system. Journal of clinical microbiology, 1998, Volume: 36, Issue:2 Topics: Amphotericin B; Anti-Bacterial Agents; Azlocillin; Culture Media; Egg Yolk; Hydrochloric Acid; Mycobacterium ulcerans; Nalidixic Acid; Oxalates; Oxalic Acid; Polyethylene Glycols; Polymyxin B; Sodium Hydroxide; Trimethoprim	1998
Reduction of contamination of mycobacterial growth indicator tubes with a modified antimicrobial combination. Journal of clinical microbiology, 2002, Volume: 40, Issue:10 Topics: Amphotericin B; Anti-Bacterial Agents; Azlocillin; Drug Interactions; Humans; Mycobacterium; Nalidixic Acid; Polymyxin B; Trimethoprim; Vancomycin	2002
CURRENT THERAPY OF INFECTIONS OF THE RENAL EXCRETORY SYSTEM. Journal of the American Geriatrics Society, 1964, Volume: 12 Topics: Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Azo Compounds; Bacitracin; Chlormerodrin; Diuretics; Drug Therapy; Erythromycin; Humans; Kanamycin; Mandelic Acids; Methenamine; Metronidazole; Nalidixic Acid; Naphthyridines; Neomycin; Nitrofurans; Nitrofurantoin; Nystatin; Organomercury Compounds; Penicillins; Polymyxins; Sulfonamides; Tetracycline; Toxicology; Urinary Tract Infections	1964
Intercalation of hydrophilic and hydrophobic antibiotics in layered double hydroxides. International journal of pharmaceutics, 2007, Mar-06, Volume: 332, Issue:1-2 Topics: Amphotericin B; Ampicillin; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Crystallography, X-Ray; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Gramicidin; Hydrophobic and Hydrophilic Interactions; Hydroxides; Membranes, Artificial; Molecular Structure; Nalidixic Acid; Nanotechnology; Sodium Cholate; Solubility; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Technology, Pharmaceutical; Time Factors; Water	2007
Reduction of contamination of mycobacterial growth indicator tubes using increased PANTA concentration. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2011, Volume: 15, Issue:2 Topics: Amphotericin B; Anti-Bacterial Agents; Azlocillin; Bacteriological Techniques; Culture Media; Disposable Equipment; Dose-Response Relationship, Drug; Equipment Contamination; Humans; Mycobacterium tuberculosis; Nalidixic Acid; Polymyxin B; Predictive Value of Tests; Prospective Studies; Sputum; Trimethoprim; Tuberculosis, Pulmonary	2011
Effect of short- and long-term antibiotic exposure on the viability of Mycobacterium avium subsp. paratuberculosis as measured by propidium monoazide F57 real time quantitative PCR and culture. Veterinary journal (London, England : 1997), 2012, Volume: 194, Issue:3 Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Azides; Colony Count, Microbial; Dose-Response Relationship, Drug; Mycobacterium avium subsp. paratuberculosis; Nalidixic Acid; Paratuberculosis; Propidium; Real-Time Polymerase Chain Reaction; Ruminants; Time Factors; Vancomycin	2012
Development of nalidixic acid amphotericin B vancomycin (NAV) medium for the isolation of Campylobacter ureolyticus from the stools of patients presenting with acute gastroenteritis. British journal of biomedical science, 2014, Volume: 71, Issue:1 Topics: Amphotericin B; Campylobacter; Culture Media; Feces; Gastroenteritis; Humans; Nalidixic Acid; Vancomycin	2014
The threat of persistent bacteria and fungi contamination in tuberculosis sputum cultures. African health sciences, 2021, Volume: 21, Issue:2 Topics: Amphotericin B; Anti-Bacterial Agents; Azlocillin; Bacteria; Bacteriological Techniques; Fungi; Humans; Longitudinal Studies; Mycobacterium tuberculosis; Nalidixic Acid; Polymyxin B; Sputum; Trimethoprim; Tuberculosis	2021